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relapse was similar (pt student= ns) when the analysis was 
done on the in silico plans. The margins reduction appears to 
avoid the inclusion in the high dose volume of about 100 cc of 
healthy brain (p=0.02) (Table 1). The target coverage was 
significantly worse in original than in the in silico plans (pt 
student <0.001) (Table 1), especially if the tumour was close 
to organs at risk (pχ2 <0.001). PTV coverage of original plans 
was significantly better with IMRT and helical-IMRT when 
compared with 3D ones (pAnova test=0.038). This difference 
was no more statistically significant with in silico planning 
(pAnova test= n.s.). Higher incidence of asthenia and leuko-
encephalopathy was observed in patients with greater 
percentage of healthy brain included in the 57 Gy isodose 
(pAnova test=0.038 and 0.034). 
 
 
 
Conclusion: No differences in the pattern of recurrence 
according to the extent of margins have been found. The 
incidence of asthenia and leuko-encephalopaty varies with 
the percentage of healthy brain included in the high dose 
volume. The margin reduction allows significant sparing of 
healthy cerebral tissue and could possibly reduce the 
incidence of late toxicity. Margin reduction is compatible 
with appropriate target coverage, thereby limiting the need 
for more sophisticated and costly techniques to selected 
cases. 
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Purpose or Objective: Elderly patients with lung cancer are 
often referred to treatment with radiotherapy. Tolerance to 
treatment and survival may be determined by their age and 
performance status. Different fractionation schedules in 
these patients can also influence the results. 
Our objective was to analyze survival in patients ≥70years, 
depending on age groups, Karnofsky Status (KPS) and 
fractionation schemes. 
 
Material and Methods: We analyzed 70 patients, aged ≥70 
years, with diagnostic of lung tumors (T1-4; N1-3), with no 
previous surgery treatments, referred for external 
radiotherapy.  
Total Dose range: 20-64Gy; fractionation schedules: 1.8-2Gy 
(considered standard, std), >2Gy 
(hypofractionation/stereotactic SBRT) Karnofsky Performance 
Status (KPS), was the tool to evaluate functional status the 
first day of treatment, and analysis was performed with two 
KPS groups: <70 vs ≥ 70 
 
 
Results: Global survival: mean 9months (m); median 8 m.  
12m survival: 22patients (31,4%)  
18m survival: 8pts (11,4%)  
>23m survival: 4pts (5,7%)  
AGE: 
70-79y: mean 9m; median 8 m  
≥80y: mean: 9,2m; median: 8 m  
KARNOFSKY PERFORMANCE STATUS (KPS) 
Survival:  
KPS <70: mean: 9,2m; median: 8  
KPS ≥70: mean: 9m; median: 8  
FRACTIONATION SCHEDULE:  
standard fx: 29 pts mean:9.2m; median: 8  
hypofractionation: 34pts mean: 8m; median: 7 m  
only SBRT: 7pts mean: 9.7m; median: 8.5m  
fractionation survival:  
≥6months: std: 20 pts (67%) hypofx: 19 (56%)  
≥12m: std: 11pts (38%) hypofx: 9pts (26.4%)  
≥18m: std: 5 pts (17.2%) hypofx: 2 pts (0,6%) 
 
Conclusion: In elderly patients the most advanced age (> 80 
years) does not determine differences in survival after 
radiotherapy treatment.  
There are no differences in survival of elderly patients 
according to the KPS (<70 vs ≥70)  
Survival is very similar regardless of the fractionation scheme 
used (mean 9.2 vs 8 months). However, 6, 12 and 18 months 
survival is greater in patients with standard fractionation We 
can conclude that in elderly patients, the variables age, KPS 
or fractionation scheme does not determine significant 
differences in survival.  
Hypofractionation techniques or SBRT should be considered 
as an alternative in frail elderly patients to avoid prolonged 
treatment in time. The analysis of other parameters such as 
tumor stage or additional chemotherapy could also 
discriminate populations with different prognostic. 
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Purpose or Objective: A baseline shift can be defined as a 
shift of the target volume relative to its surrounding organs 
at risk (OAR). The baseline shift varies from day to day and 
can potentially lead to an overdosage of the OARs. In our 
clinic, the magnitude of the baseline shift is measured at the 
start of treatment in patients treated for solitary lung 
cancer. In case an OAR moves towards the target and the 
baseline shift exceeds the PRV margin, treatment is 
prevented. Limited data is available about the intra-
fractional change of the baseline shift. The aim of this study 
is to determine if an intra-fractional change of the baseline 
shift necessitates multiple measurements to ensure safe 
delivery of SBRT. 
 
Material and Methods: In this study a retrospective analysis 
was performed using the data of 87 patients, treated for lung 
cancer with SBRT in the period January 2010 to February 
2014. Patients were treated according to one of three 
protocols: 3x18Gy (n=19), 5x11Gy (n=47), or 8x7.5Gy (n=21). 
Treatment delivery was performed using multiple (> 9) non-
coplanar conformal beams or VMAT using 2 arcs. A planning 
risk volume (PRV) margin of 10mm was used standard around 
OARs (e.g. the heart and spinal cord). Smaller PRV margins, 
with a minimum of 3mm, were used in case 
prescriptions/constraints could not be met during planning.  
Conebeam-CT scans were performed at the beginning, 
halfway, and at the end of each treatment fraction. Grey-
value registrations of Conebeam-CT scans with Planning-CT 
scan were performed for both the target and the patient 
specific most critical OAR . The difference between the 
registrations is the baseline shift. The number of times the 
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vector length of the baseline shift exceeded the PRV margin 
during treatment was scored. In these cases, it was 
investigated whether or not this would result in overdose for 
the OAR.  
Furthermore, the change in baseline shift was calculated for 
the first and second half of each fraction as well as for the 
fraction as a whole. The average vector length and standard 
deviation of the change in baseline shift were determined per 
patient and for the population as a whole. Data were 
stratified according to the applied protocol.  
 
Results: Figure 1 shows the results of change in baseline shift 
during treatment. Slightly larger changes in baseline shift 
were seen in the 3x18Gy and 5x11Gy protocol. In 11 out of 
460 treatment fractions, the baseline shift exceeded the PRV 
margin at the end of the treatment fraction. In none of the 
patients this exceeding led to overdosage. 
 
 
Conclusion: Intra-fractional baseline shift can vary 
substantially during treatment, especially in patients treated 
with a 3x18Gy or 5x11Gy protocol. However, clinical impact 
of changes in baseline shift during treatment were not found 
in this study. A single assessment of the baseline shift at the 
start of treatment ensures a safe treatment delivery. 
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Purpose or Objective: In our institution, orthogonal kV X-
rays is at present the preferred imaging method for children 
as imaging dose is a concern. In this study, we varied the 
CBCT acquisition parameters and investigated how much we 
can reduce dose, and still be able to perform a secure bone 
match in clinical practice. 
 
Material and Methods: An Alderson phantom equivalent to an 
adult was CT scanned. Due to the absence of a real child size 
phantom only the head and neck was used. On our Varian 
Novalis Tx accelerator, we performed 12 full-fan 200° CBCT 
scans with different parameter settings. The number of 
projections, mA and ms were systematically decreased, while 
kV was constantly at 100. After each scan an automatic bone 
match was performed to investigate the ability to perform 
this kind of match, since this is our procedure in clinical 
practice. The image quality of the scans was visually 
inspected for noise and artefacts. Six of the scans were 
chosen for dose measurements relative to the standard 
preset for these types of scans. The relative dose 
measurements were performed using the RTI Barracuda 
system, consisting of a DCT10-pencil ion chamber positioned 
in the centre of the CTDI 16 cm diameter cylindrical 
phantom. The parameters from the scan comprising the 
largest dose reduction and with the ability to match were 
used for a new CBCT preset. The phantom was CBCT scanned 
with the old and the new preset. Additionally the phantom 
was four times repositioned slightly different and re-scanned. 
Four RTT’s independently matched these CBCT scans with the 
original CT scan offline in order to validate the new preset. 
 
Results: A dose reduction of up to a factor of 14 could be 
achieved by changing the full-fan CBCT scan parameters from 
20 mA and 20 ms (standard preset) to 10 mA and 2 ms. 
Reducing the number of projections from 650 to 360 added 
no further dose reduction. The new imaging preset results in 
a total dose of only 0.39 mGy compared to 0.14 mGy for 2 
orthogonal X-ray imaging. Table 1 shows the average match 
difference between the different presets. The maximum 
deviations are +/-0,5 mm and 0.6º. Figure 1a+b show the 
difference in image quality between the standard and the 
new preset. 
 
 
 
Conclusion: It is possible for RTT’s to use low dose daily 
CBCT scans in paediatric radiation therapy and still perform a 
reliable automatic bone match. 
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Purpose or Objective: This work develops risk assessments of 
solid secondary malignancies (SMN) after radiotherapy (RT) in 
survivors of childhood and adolescent Hodgkin Lymphoma 
(HL) patients (pts) using the Schneider’s dose-response model 
for solid cancers induction (Theoretical Biology and Medical 
Modelling 2011), comparing conventional technique (3D-CRT) 
with IMRT delivered with Helical Tomotherapy (HT). 
 
